Investigator Responsibilities in Protecting Participants in the Conduct of Bioequivalence Studies Cecilia C. Maramba, MD, MScID

First Page		Document Content
Date: 2010-02-19 02:38:05 Pharmacokinetics Pharmaceutical industry Clinical research Bioequivalence Generic drug Bioavailability Food and Drug Administration Clinical trial Pharmaceutical drug Abbreviated New Drug Application		Investigator Responsibilities in Protecting Participants in the Conduct of Bioequivalence Studies Cecilia C. Maramba, MD, MScID Add to Reading List Source URL: www.fercap-sidcer.org Download Document from Source Website File Size: 450,71 KB Share Document on Facebook

	Investigator Responsibilities in Protecting Participants in the Conduct of Bioequivalence Studies Cecilia C. Maramba, MD, MScID DocID: 1ptht - View Document
	PUBLIC LAW 105–115—NOV. 21, 1997 FOOD AND DRUG ADMINISTRATION MODERIZATION ACT OF 1997 111 STAT. 2296 DocID: 1pnIy - View Document
	Updating ANDA Labeling After the Marketing Application for the Reference Listed Drug Has Been Withdrawn Guidance for Industry DocID: 1p93k - View Document
	Case 2:06-cvHAA-ES Document 71 FiledPage 1 of 45 PageID: 1673 NOT FOR PUBLICATION UNITED STATES DISTRICT COURT DocID: 1m2hg - View Document
	Microsoft Word - 10CV5118 Seattle Childrens Hosp v Akorn MTD.doc DocID: 1lmCl - View Document